@article{Guida_Urtis_Rubino_Pellacani_Farnetani_2016, place={Quartu Sant’Elena (CA, Italy)}, title={Congenital melanocytic nevi management: answer}, volume={5}, url={https://jpnim.com/index.php/jpnim/article/view/050128}, DOI={10.7363/050128}, abstractNote={Congenital melanocytic nevi (CMN) are melanocytic lesions presenting at birth or appearing during the first weeks of life. CMN are usually grouped, according to size, in three categories: 1) small congenital nevi (SCN), measuring less than 1.5 cm in greatest diameter; 2) intermediate congenital nevi (ICN) that are 1.5-19.9 cm in greatest diameter; 3) large or giant nevi, larger than 20 cm in greatest diameter. Although the risk of a nevus evolving into a melanoma is low, all congenital nevi, particularly giant nevi, can be considered potential melanoma precursors. Furthermore, other criteria should be considered for an appropriate management of these lesions.<br /><br />}, number={1}, journal={Journal of Pediatric and Neonatal Individualized Medicine (JPNIM)}, author={Guida, Stefania and Urtis, Giacomo Giovanni and Rubino, Giuseppe and Pellacani, Giovanni and Farnetani, Francesca}, year={2016}, month={Mar.}, pages={e050128} }